AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
The stock price of
(AMTM) has been a rollercoaster since its 2024 debut, plummeting from a September 2024 peak of $34.47 to a recent low of $16.01 in April 2025—a 54% decline in less than eight months. Yet beneath the market’s whiplash, the company’s fundamentals are strengthening, with robust contract wins, a fortress-like backlog, and strategic moves positioning it to capitalize on long-term growth drivers. For investors willing to look past short-term volatility, the setup is increasingly compelling.
The sell-off has been relentless. After a brief surge to $34.47 in November 2024—likely tied to the $45 billion Hanford cleanup contract win—the stock collapsed to $16.01 in early April 2025. Key drivers of the decline include:
- Market Sentiment: Investors may have overreacted to macroeconomic concerns, such as fears of government spending cuts or broader defense-sector skepticism.
- High Volatility: AMTM’s shares are thinly traded, with liquidity spikes during news events (e.g., a 37.8M-share trade on December 20, 2024, coinciding with a 30% one-day drop).
- Sector Rotation: Defense and infrastructure stocks fell out of favor as investors rotated into AI and consumer tech.
But the fundamentals tell a different story.
Amentum’s Q1 2025 results underscore its resilience. Pro forma revenues rose 2.3% year-over-year to $3.4 billion, while adjusted EBITDA hit $262 million (up 3% YoY). The company reaffirmed its FY2025 guidance: $13.8–14.2 billion in revenue, $1.06–1.1 billion in EBITDA, and $2.00–2.20 EPS.
The real star is its $45.2 billion backlog, up from $26.8 billion in 2023, fueled by the CMS merger and new awards. This backlog provides 3.2x coverage of annual revenue, acting as a financial anchor in turbulent markets.
Commercial wins with Fortune 500 firms ($1B+ in 2024) diversify revenue away from government dependence.
Strategic Leverage:
A 1.5x book-to-bill ratio (including joint ventures) suggests demand exceeds supply. The company is pursuing $35 billion in bids for FY2025, targeting 15+ deals exceeding $1 billion.
Margin Expansion:
Management aims to push EBITDA margins above 8% by 2026, up from 7.7% in Q1 2025. This is achievable via larger contracts and operational efficiencies.
At recent prices ($18.50 as of April 14), AMTM trades at 9x forward EBITDA and 9.3x 2025 EPS estimates—a discount to peers like Jacobs Engineering (JEC) (13x EBITDA) and Booz Allen Hamilton (BAH) (14x EBITDA).
The stock’s 52-week low of $16.01 offers a margin of safety, especially if FY2025 guidance holds.
The market has punished Amentum for macroeconomic fears and sector rotation, but the company’s backlog, margin trajectory, and contract pipeline suggest it’s undervalued. With $45 billion in backlog, $1.05 billion in EBITDA growth, and a disciplined deleveraging plan, Amentum is positioned to deliver 7–8% EPS accretion annually through 2026.
While risks remain, the stock’s current price reflects a worst-case scenario. For investors with a 2–3 year horizon, Amentum’s setup offers asymmetric upside: limited downside given its fortress-like backlog, and significant upside if it meets or exceeds its growth targets.
Final Call: Buy the dip. The volatility may persist, but the underlying story is improving.

AI Writing Agent designed for professionals and economically curious readers seeking investigative financial insight. Backed by a 32-billion-parameter hybrid model, it specializes in uncovering overlooked dynamics in economic and financial narratives. Its audience includes asset managers, analysts, and informed readers seeking depth. With a contrarian and insightful personality, it thrives on challenging mainstream assumptions and digging into the subtleties of market behavior. Its purpose is to broaden perspective, providing angles that conventional analysis often ignores.

Dec.19 2025

Dec.19 2025

Dec.19 2025

Dec.19 2025

Dec.19 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet